KR850004398A - Waxes, Antigens and Antibodies for Treatment of Kawasaki Disease - Google Patents
Waxes, Antigens and Antibodies for Treatment of Kawasaki Disease Download PDFInfo
- Publication number
- KR850004398A KR850004398A KR1019840008490A KR840008490A KR850004398A KR 850004398 A KR850004398 A KR 850004398A KR 1019840008490 A KR1019840008490 A KR 1019840008490A KR 840008490 A KR840008490 A KR 840008490A KR 850004398 A KR850004398 A KR 850004398A
- Authority
- KR
- South Korea
- Prior art keywords
- streptococcus
- antigen
- microorganism belonging
- mammal
- mutant strain
- Prior art date
Links
- 239000000427 antigen Substances 0.000 title claims description 11
- 102000036639 antigens Human genes 0.000 title claims description 11
- 108091007433 antigens Proteins 0.000 title claims description 11
- 208000011200 Kawasaki disease Diseases 0.000 title description 2
- 208000001725 mucocutaneous lymph node syndrome Diseases 0.000 title description 2
- 239000001993 wax Substances 0.000 title description 2
- 241000194017 Streptococcus Species 0.000 claims 13
- 244000005700 microbiome Species 0.000 claims 11
- 238000000034 method Methods 0.000 claims 6
- 241000124008 Mammalia Species 0.000 claims 5
- 210000004027 cell Anatomy 0.000 claims 4
- 208000015181 infectious disease Diseases 0.000 claims 4
- 230000002401 inhibitory effect Effects 0.000 claims 3
- 239000000243 solution Substances 0.000 claims 3
- 241001465754 Metazoa Species 0.000 claims 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims 2
- 239000004480 active ingredient Substances 0.000 claims 2
- 238000004108 freeze drying Methods 0.000 claims 2
- 230000003053 immunization Effects 0.000 claims 2
- 230000000415 inactivating effect Effects 0.000 claims 2
- 238000002360 preparation method Methods 0.000 claims 2
- 210000002966 serum Anatomy 0.000 claims 2
- 239000011780 sodium chloride Substances 0.000 claims 2
- 239000002344 surface layer Substances 0.000 claims 2
- 208000008771 Lymphadenopathy Diseases 0.000 claims 1
- 230000001154 acute effect Effects 0.000 claims 1
- 150000003863 ammonium salts Chemical class 0.000 claims 1
- 239000000872 buffer Substances 0.000 claims 1
- 239000007853 buffer solution Substances 0.000 claims 1
- 230000002708 enhancing effect Effects 0.000 claims 1
- 210000004195 gingiva Anatomy 0.000 claims 1
- 239000001963 growth medium Substances 0.000 claims 1
- 238000002955 isolation Methods 0.000 claims 1
- 208000018555 lymphatic system disease Diseases 0.000 claims 1
- 239000002207 metabolite Substances 0.000 claims 1
- 239000002184 metal Chemical class 0.000 claims 1
- 230000000813 microbial effect Effects 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
내용 없음No content
Description
[발명의 명칭[Name of invention]
가와사끼병 처리용 왁진, 항원 및 항체Waxes, Antigens and Antibodies for Treatment of Kawasaki Disease
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음As this is a public information case, the full text was not included.
Claims (9)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP58-251,976 | 1983-12-28 | ||
JP58251976A JPS60243024A (en) | 1983-12-29 | 1983-12-29 | Vaccine for preventing infections disease caused by streptococcus sanguis, and antigen and antibody for diagnosis |
Publications (1)
Publication Number | Publication Date |
---|---|
KR850004398A true KR850004398A (en) | 1985-07-15 |
Family
ID=17230796
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019840008490A KR850004398A (en) | 1983-12-28 | 1984-12-28 | Waxes, Antigens and Antibodies for Treatment of Kawasaki Disease |
Country Status (2)
Country | Link |
---|---|
JP (1) | JPS60243024A (en) |
KR (1) | KR850004398A (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS60190707A (en) * | 1984-03-09 | 1985-09-28 | Advance Res & Dev Co Ltd | Cariostatic agent |
US10946085B2 (en) * | 2016-02-15 | 2021-03-16 | Hipra Scientific, S.L.U. | Streptococcus uberis extract as an immunogenic agent |
-
1983
- 1983-12-29 JP JP58251976A patent/JPS60243024A/en active Pending
-
1984
- 1984-12-28 KR KR1019840008490A patent/KR850004398A/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
JPS60243024A (en) | 1985-12-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2773816B2 (en) | Methods for analyzing the presence of Chlamydia infection and species-specific antigens of Chlamydia trachomatis | |
ES2198405T3 (en) | TYPE I SURFACE ANTIGENS ASSOCIATED WITH STAPHYLOCOCCUS EPIDERMIS. | |
Lancefield | Type-specific antigens, M and T, of matt and glossy variants of group A hemolytic streptococci | |
Raizman et al. | Detection of circulating antigen in acute experimental infections with Toxoplasma gondii | |
DE2967036D1 (en) | Vaccine and method of making | |
Brown et al. | Human foamy virus: further characterization, seroepidemiology, and relationship to chimpanzee foamy viruses | |
DE3175677D1 (en) | Polysaccharide antigen from streptococcus and vaccines | |
Lambert Jr et al. | Identification of Actinomyces israelii and Actinomyces naeslundii by fluorescent-antibody and agar-gel diffusion techniques | |
US5610059A (en) | Etiological agent for porcine enteritis | |
IE940698L (en) | Vaccine and serum for endotoxin associated disease and method of preparing same as well as to methods of immunization and treatment of such disease and to a detoxified endotoxin and bacterial mutant | |
Joly et al. | Antigenic analysis of Legionella pneumophila and Tatlockia micdadei (Legionella micdadei) by two-dimensional (crossed) immunoelectrophoresis | |
Vennes et al. | Antigenic analysis of cell structures isolated from Bacillus megaterium | |
Schachte | Immunization of channel catfish, Ictalurus punctatus, against two bacterial diseases | |
Schmidt et al. | Immunodiffusion reactions with rubella antigens | |
KR850004398A (en) | Waxes, Antigens and Antibodies for Treatment of Kawasaki Disease | |
Jensen | Production And Evaluation Of Antisera For Serological Type Determination Of Group‐B Streptococci by Double Diffusion In Agarose Gel | |
Nayar et al. | Infectious bovine keratoconjunctivitis II. Antibodies in lacrimal secretions of cattle naturally or experimentally infected with Moraxella bovis. | |
Stavitsky | Characteristics of pathogenic spirochetes and spirochetoses with special reference to the mechanisms of host resistance | |
McMillan et al. | Serum immunoglobulin response in uncomplicated gonorrhoea. | |
Reimann et al. | AN INDIRECT HAEMAGGLUTINATION TEST FOR DEMONSTRATION OF GONOCOCCAL ANTIBODIES USING GONOCOCCAL PILI AS ANTIGEN: Methodology and Preliminary Results | |
JPS61185183A (en) | Hybrid cell system for producing cell lytic monoclonal antibody to vagina trichomonas | |
Danielsson et al. | Rapid serotyping of groups A, B, and C meningococci by rocket-line immunoelectrophoresis and co-agglutination. | |
US4539201A (en) | Medicament and method for inducing immunity to infectious bovine keratoconjunctivitis | |
Labzoffsky et al. | New complement fixing antigen for serodiagnosis of gonorrhoea | |
YANO et al. | Serological differentiation of bacteria belonging to the Xanthomonas campestris group by indirect hemagglutination test |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WITN | Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid |